Results 121 to 130 of about 23,834 (214)
Integrative proteomics reveals MSH6 to modulate PARP inhibitor sensitivity in BRCA1/2-proficient ovarian cancer. [PDF]
Deng O +9 more
europepmc +1 more source
We present the case of a 69-year-old male diagnosed with stage IV perihilar cholangiocarcinoma with loss of expression of MSH2 and MSH6 proteins, but somatic wild type MSH2 and MSH6 genes with Oncomine Comprehensive Assay (OCA) genomic sequencing panel ...
Gutiérrez Pérez, César +6 more
core +1 more source
Redundant mispair excision mechanisms in eukaryotic DNA mismatch repair. [PDF]
Putnam CD, Kolodner RD.
europepmc +1 more source
Loss of MSH6 or MSH2 sensitizes progressive glioblastoma to radiotherapy. [PDF]
Moisoiu V +15 more
europepmc +1 more source
An update on APC I1307K homozygosity: observations from a large multigene panel testing cohort. [PDF]
Zaretsky L +7 more
europepmc +1 more source
Bayesian Integration of Tumor Mutational Signatures and Somatic Features Refines Pathogenicity Assessment of Germline Mismatch Repair Variants. [PDF]
Amzaleg Y +6 more
europepmc +1 more source

